Brief: Update On FDA Review Of VTAMA Cream 1% For Atopic Dermatitis In Adults And Children Aged 2 And Older

Organon & Co.

05/11/2024 12:31

Nov 5 (Reuters) - Organon & Co  OGN.N :
    * UPDATE ON FDA REVIEW OF VTAMA® (TAPINAROF) CREAM, 1% FOR
THE
TREATMENT OF ATOPIC DERMATITIS IN ADULTS AND CHILDREN 2 YEARS OF
AGE AND OLDER
    * ORGANON & CO - FDA EXTENDS REVIEW DATE FOR ORGANON'S VTAMA
CREAM
    * ORGANON & CO - NEW TARGET DATE FOR VTAMA REVIEW IS MARCH
12,
2025
    * ORGANON & CO - FDA RAISES NO SAFETY OR EFFICACY CONCERNS
FOR
VTAMA

Source text:  ID:nBw3tJy7Ga 
Further company coverage:  OGN.N 

 ((Reuters.Briefs@thomsonreuters.com;))